<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04538534</url>
  </required_header>
  <id_info>
    <org_study_id>TN2020-NA T -INS-39</org_study_id>
    <nct_id>NCT04538534</nct_id>
  </id_info>
  <brief_title>Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention</brief_title>
  <official_title>Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pr. Semir Nouira</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Monastir</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radial artery is the recommended route for percutaneous coronary intervention for it&#xD;
      significantly reduces net adverse clinical events compared to the femoral approach. The&#xD;
      success of the radial approach is therefore of a paramount importance. However, radial artery&#xD;
      spasm (RAS) remains one of the major limitations of transradial approach (TRA) and the most&#xD;
      frequent cause of TRA failure. Several recommendations has been issued to improve success&#xD;
      rate when using the radial route.&#xD;
&#xD;
      In the Tunisian difficult economic context, the use of low end equipment, the unavailability&#xD;
      of nitroglycerine and calcium antagonist verapamil, has led to the general feeling that RAS&#xD;
      and TRA failure has subsequently increased.&#xD;
&#xD;
      The standard and only used protocol by the Tunisian interventional cardiologist, consists of&#xD;
      administrating 1 mg isosorbide dinitrate through the arterial sheath immediately after radial&#xD;
      arterial puncture, therefore limiting the options to prevent RAS.&#xD;
&#xD;
      Nicardipine is the only injectable calcium antagonist available in Tunisia. Its spasmolytic&#xD;
      action on radial artery has been well demonstrated when used in CABG. However, it has been&#xD;
      very poorly investigated in trans radial percutaneous coronary intervention.&#xD;
&#xD;
      Investigators believe that the concomitant use of nicardipine with isorbide might&#xD;
      significantly reduce RAS and TRA failure when compared to isosorbide dinitrate only.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants in which radial artery spasm occurred</measure>
    <time_frame>24 hours</time_frame>
    <description>Significant limitation of the catheter movement perceived by the operator together with mild to severe pain in the forearm of the patient or the need of repeating vasodilator administration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants in which severe radial artery spasm occurred</measure>
    <time_frame>24 hours</time_frame>
    <description>Complete catheter blockage [i.e., the catheter cannot be moved back or forth], severe pain with need for morphine or midazolam injections, crossover to the contralateral radial or femoral artery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Spasm Artery</condition>
  <arm_group>
    <arm_group_label>nicardipine and isosorbide dinitrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A Cocktail of 1 mg of Isosorbide Dinitrate associated to 1 mg of nicardipine will be put in a syringe than diluted in saline serum to have a volume of 3cc.&#xD;
The obtained solution will be administered in an intra-arterial fashion via the trans-radial sheath after randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>isosorbide dinitrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Isosorbide Dinitrate: 1 mg will be diluted in saline solution as to have a 3cc volume The obtained solution will be administered in an intra-arterial fashion via the trans-radial sheath after randomization</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicardipine</intervention_name>
    <description>To compare the association of nicardipine and isosorbide dinitrate vs isosorbide dinitrate alone on the rate of occurrence of radial artery spasm</description>
    <arm_group_label>isosorbide dinitrate</arm_group_label>
    <arm_group_label>nicardipine and isosorbide dinitrate</arm_group_label>
    <other_name>Loxen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients scheduled for coronary intervention will be eligible for screening&#xD;
             (coronarography or coronary angioplasty).&#xD;
&#xD;
          -  Participant is willing and is able to give informed consent for participating in the&#xD;
             trial.&#xD;
&#xD;
          -  Male or Female, aged 18 years or above.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Planned femoral approach because no radial pulse was perceived&#xD;
&#xD;
          -  Cardiogenic shock&#xD;
&#xD;
          -  Coronary intervention for ST elevation myocardial infarction during the night shift.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Fattouma Bourguiba</name>
      <address>
        <city>Monastir</city>
        <zip>5000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>semir nouira, Pr</last_name>
      <phone>52432582</phone>
      <email>semir.nouira@rns.tn</email>
    </contact>
    <investigator>
      <last_name>Nidhal Bouchahda, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2020</study_first_submitted>
  <study_first_submitted_qc>August 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 4, 2020</study_first_posted>
  <last_update_submitted>June 20, 2021</last_update_submitted>
  <last_update_submitted_qc>June 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Monastir</investigator_affiliation>
    <investigator_full_name>Pr. Semir Nouira</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>radial artery spasm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicardipine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

